Myasthenia gravis: subgroup classification and therapeutic strategies.
Gilhus NE, Verschuuren JJ.
Lancet Neurol. 2015 Oct;14(10):1023-36. doi: 10.1016/S1474-4422(15)00145-3.
Myasthenia Gravis.
Gilhus NE.
N Engl J Med. 2016 Dec 29;375(26):2570-2581. doi: 10.1056/NEJMra1602678.
[Myasthenia gravis and pregnancy: impact and approach].
Alfaro-Paredes K, Aguilar-Ydiáquez C, Aguirre-Flores R, Schulz-Cáceres H.
Rev Neurol. 2022 Sep 1;75(5):117-122. doi: 10.33588/rn.7505.2022207.
Pediatric Myasthenia Gravis.
Peragallo JH.
Semin Pediatr Neurol. 2017 May;24(2):116-121. doi: 10.1016/j.spen.2017.04.003. Epub 2017 Apr 7.
Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and Epidemiology.
Hehir MK, Silvestri NJ.
Neurol Clin. 2018 May;36(2):253-260. doi: 10.1016/j.ncl.2018.01.002.
Myasthenia gravis: a clinical-immunological update.
Binks S, Vincent A, Palace J.
J Neurol. 2016 Apr;263(4):826-34. doi: 10.1007/s00415-015-7963-5. Epub 2015 Dec 24.
Myasthenia gravis: an update for the clinician.
Sieb JP.
Clin Exp Immunol. 2014 Mar;175(3):408-18. doi: 10.1111/cei.12217.
[An update on myasthenia gravis].
Martínez Torre S, Gómez Molinero I, Martínez Girón R.
Semergen. 2018 Jul-Aug;44(5):351-354. doi: 10.1016/j.semerg.2018.01.003. Epub 2018 Mar 17.
Myasthenia gravis in 2025: five new things and four hopes for the future.
Binks SNM, Morse IM, Ashraghi M, Vincent A, Waters P, Leite MI.
J Neurol. 2025 Feb 22;272(3):226. doi: 10.1007/s00415-025-12922-7.
Myasthenia gravis.
Linton DM, Philcox D.
Dis Mon. 1990 Nov;36(11):593-637. doi: 10.1016/0011-5029(90)90006-d.
